News
ZEISS Group has evolved its use of Celonis from a simple audit tool in 2017 to a strategic Process Intelligence platform ...
U.S. President Donald Trump vowed to become the first "crypto president" before he took office. He has since wooed the ...
"We bought our price point down, and we merged the two brands that we had at the time into one," Beckham said.
The "Big Beautiful Bill," which passed in the House, includes new provisions for bonus depreciation, R&D deductions, and pass ...
AI is both a threat and an opportunity for creative communities – and copyright is just one issue in a complex sector. Here's ...
Yields on 40-year Japanese government bonds (JGBs) had hit a record high 3.675% last week and were down 40 basis points from ...
MANCHESTER UNITED are preparing for a HUGE summer transfer window – after missing out on Champions League football and a poor ...
Healthscope was put into receivership on Monday, placing the future of 38 hospitals, 19,000 staff and hundreds of thousands ...
Federal Judge Richard Leon on Tuesday ruled that Donald Trump's executive order targeting the Big Law firm WilmerHale amounts ...
ARSENAL are looking ahead to a busy summer transfer window after another trophyless season. Sporting director Andrea Berta ...
The following new stocks to watch admittedly may never deliver those kinds of gains. But there is undoubtedly interest in ...
Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results